SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-034632
Filing Date
2023-09-28
Accepted
2023-09-28 16:16:48
Documents
78
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 3124493
2 ex14-1.htm EX-14.1 50994
3 ex21-1.htm EX-21.1 3650
4 ex23-1.htm EX-23.1 4996
5 ex31-1.htm EX-31.1 12003
6 ex31-2.htm EX-31.2 12535
7 ex32-1.htm EX-32.1 6300
8 fin_001.jpg GRAPHIC 7745
  Complete submission text file 0001493152-23-034632.txt   13250923

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE ppcb-20230630.xsd EX-101.SCH 80311
10 XBRL CALCULATION FILE ppcb-20230630_cal.xml EX-101.CAL 76355
11 XBRL DEFINITION FILE ppcb-20230630_def.xml EX-101.DEF 389277
12 XBRL LABEL FILE ppcb-20230630_lab.xml EX-101.LAB 646653
13 XBRL PRESENTATION FILE ppcb-20230630_pre.xml EX-101.PRE 501364
72 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1897957
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

IRS No.: 330662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-54878 | Film No.: 231289889
SIC: 2834 Pharmaceutical Preparations